CAMP

Finalized
Category: Process & Manufacturing Research & Discovery Funding: VINNOVA

THE SCIENCE AND TECHNOLOGY TO TRANSLATE ATMPs FROM LAB TO CLINIC

CAMP is a national competence centre in Vinnova’s research program for biological medicines. The centre focuses on the science and technology required to translate ATMPs from lab to clinic, including bioprocess development, GMP production and logistics. CAMP drives collaboration between researchers, GMP competent resources, industry and hospitals. CAMP gathers all of the university hospitals in Sweden, all research institutes with significant activity in ATMP and both large and small companies active in the ATMP field.

Coordinator: Umeå universitet

WORK PACKAGES

  • Process Development
  • Infrastructure for GMP manufacturing
  • Quality control, shelf-life and logistics

The overall long term objective is to develop general cell processing development principles and methods for an effective transfer from preclinical to clinical, GMP-compatible production.

Contact: Jukka Lausmaa – Centre Director, Paul Kingham – Centre Coordinator

Partners

Akademiska sjukhuset
Amniotics
AstraZeneca
Bico Group
Celgene
Cellastra
Cytiva
Elicera Therapeutics
Göteborgs universitet
Karolinska Institutet
Karolinska Universitetssjukhuset
GBA Key2Compliance
KTH
LIF
Linköpings universitet
Lunds universitet
MAGic Bioprocessing
Medicon Village
Miltenyi Biotec
MitoSense
NEOGAP Therapeutics
NextCell Pharma
Noricon
NorthX Biologics
Novartis
Region Örebro län
Region Skåne
Region Västerbotten
Region Östergötland
RISE
SVF Vaccines
Umeå universitet
Uppsala universitet
Västra Götalandsregionen
VERIGRAFT
VivaBioCell S.p.A.
Xintela
XNK Therapeutics
Your Special Delivery Service